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Abstract
Background: In the early stage of diabetes, the cardiac ejection fraction is preserved, despite the existence of the
subclinical cardiac dysfunction to some extent. However, the detailed phenotype of this dysfunction and the
underlying mechanism remain unclear. To improve our understanding of this issue, we used low-dose STZ and
high-fat diet to induce type 2 diabetic models in rats. The effects and the mechanism associated with the early
stages of the disease were analyzed.
Methods: The type 2 diabetic mellitus (T2DM) in SD rats were induced through 30 mg/kg STZ and high-fat diet.
Two-dimensional spackle-tracking echocardiography (STE) and the dobutamine test were performed to examine
the cardiac function. Calcium transients of left ventricular myocytes were detected and the related intracellular
signalling factors were analyzed by western blotting.
Results: After 6-weeks, T2DM rats in left ventricular (LV) diastole showed decreased global and segment strain(S)
levels (P < 0.05), both in the radial and circumferential directions. Strain rate (Sr) abatement occurred in three
segments in the radial and circumferential directions (P < 0.05), and the radial global Sr also decreased (P < 0.05).
In the systolic LV, radial Sr was reduced, except the segment of the anterior septum, and the Sr of the lateral wall
and post septum decreased in the circumferential direction (P < 0.05). Conventional M-mode echocardiography
failed to detect significant alterations of cardiac performance between the two groups even after 12 weeks, and
the decreased ejection fraction (EF%), fractional shortening (FS%) and end-systolic diameters (ESD) could be
detected only under stress conditions induced by dobutamine (P < 0.05). In terms of calcium transients in cardiac
myocytes, the Tpeak in model rats at 6 weeks was not affected, while the Tdecay1/2 was higher than that of the
controls (P < 0.05), and both showed a dose-dependent delay after isoproterenol treatment (P < 0.05). Western
blot analysis showed that in 6-week T2DM rats, myocardial p-PLB expression was elevated, whereas p-CaMKII,
p-AMPK and Sirt1 were significantly down-regulated (P < 0.05).
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Conclusion: A rat model of T2DM was established by low dose STZ and a high-fat diet. LV deformation was
observed in the early stages of T2DM in association with the delay of Ca2+ transients in cardiomyocytes due to
the decreased phosphorylation of CaMKII. Myocardial metabolism remodeling might contribute to the early LV
function and calcium transportation abnormalities.
Keywords: Diabetic cardiomyopathy, Diabetes mellitus, Speckle tracking echocardiography, Rat, Ca(2+) transient,
CaMKII, AMPK, Sirt1
Background
Diabetic cardiomyopathy (DCM) can impair cardiac
performance, which will eventually develop into global
cardiac dysfunction and contribute heavily to the high
mortality of diabetes population [1]. Although cardiac
dysfunction is one of the main complications in such
disease, clinical studies have shown that asymptomatic
diastolic and/or systolic dysfunction occurred in the
early stage of diabetes with preserved left ventricular
(LV) ejection fraction [2, 3]. Therefore, for therapeutic
purpose, it is critical to identify the subclinical cardiac
dysfunction as early as possible and elucidate the under-
lying mechanism(s).
Two-dimensional speckle tracking echocardiography
(STE) may calculate strain and strain rate to evaluate re-
gional and/or global cardiac wall motion tracks during
cardiac cycle [4, 5]. Because of its angle-independency,
two-dimensional STE can minimize the variability dur-
ing the quantification of regional and global ventricular
function and is very sensitive for the detection of cardiac
dysfunction in the early stages of diabetes [6]. This tech-
nology is currently applied to patients with diabetes to
monitor cardiac performance; however, although there
have had some studies in clinic, the reports about the
data on the early stages of this disease in animal models
are only a few [7, 8]. To clarify this issue, in the present
study, we designed a protocol based on the use of STE
to monitor cardiac performance in a type 2 diabetes
mellitus (T2DM) rat model, and analyzed the cardio-
myocyte intracellular calcium signaling pathway to im-
prove our understanding of the mechanisms underlying
the changes that occur during disease development.
Methods
Chemicals and animal foods
Joklik’s modified Minimum Essential Medium Eagle
(MEM), collagenase (type I), fetal bovine serum (FBS)
and STZ were purchased from Sigma. Fluro-4/AM was
obtained from Invitrogen, whereas rat insulin ELISA test
kit was obtained from Millipore. Standard laboratory
animal food was purchased from Guangdong Provincial
Medical Experimental Animal Center containing 3 % fat,
20%protein, 55 % carbohydrate with 310 kJ/kg total calo-
rific value. High-fat food was made from the same place,
containing15% butter, 10 % egg yolk powder, 2 % choles-
terol and 73 % standard food providing 412 kJ/kg calorie
for animals.
Experimental animals
Thirty-six male Sprague–Dawley (SD) rats in age of about
8 weeks with the weight of about 200 g were purchased
from Guangdong Provincial Medical Experimental Animal
Center. Rats were housed under a 12-h light–dark cycle
and were fed with standard chow for 7 days prior to treat-
ment and tap water ad libitum. The room temperature
was kept at 22 ± 2 °C. All stressful conditions were
avoided.
The maintenance of animals was under the Guide for
the Care and Use of Laboratory Animals published by
the US National Institute of Health (1996). Experimental
protocols were approved by the research ethic commit-
tee of Guangdong General Hospital.
Induction and identification of type 2 diabetes
The design of the protocol was came from previous re-
ports [9, 10] and was amended slightly. In brief, after
one week of normal feeding, rats were randomly divided
into two groups: control (16 rats) and model (20 rats).
Twelve hours before treatment, food was withdrawn
from housing cages except for the water supply. In the
model group, rats were injected with 30 mg/kg of STZ
from tail vein, which was prepared in 0.1 M citrate buf-
fer (pH4.5) right before use. Then, the animals were fed
with the high-fat diet. In the control group, rats were
injected with the same solution of the model but with
the absence of STZ and fed with normal diet as before.
Fasting plasma glucose (FPG), random plasma glu-
cose (RPG) measurement and oral glucose tolerance
test (OGTT) were performed to monitor the change of
the concentration of blood glucose in rats. Initially, be-
fore fasted, blood sample from tail vein of rats after
7 days of induction treatment was obtained to detect
the RPG, and then all rats were starved for further ex-
periments. After 12-h overnight starvation, blood sam-
ples for test were collected from rat’s tail vein at 0, 30,
60, 90,120mins after glucose lavage (at 1 g/kg of body
weight). Fasting serum samples were also collected for
insulin concentration analysis by ELISA assay and
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plasma glucose concentrations were measured through
Roche Accu-Chek Performa.
Traditional echocardiography
At 6 weeks, rats were anaesthetized with isoflurane
(1.5 % isoflurane and 98.5 % O2) and placed on a heating
pad in supine position. Echocardiography images were
obtained with 16 MHz detector (VevoStrain 2100,
VisualSonics, Toronto, ON, Canada). In each group, left
ventricle M-mode images were acquired from paraster-
nal short axis view at the mid papillary muscle level.
Measurement included end-diastolic and end-systolic LV
anterior wall thickness (AWD and AWS, respectively),
end-diastolic posterior wall thickness (PWD) and diame-
ters (EDD), end-diastolic and end-systolic LV volumes
(EDV and ESV, respectively), ejection fraction (EF) and
fractional shortening (FS). In addition, diastolic function
was assessed using colourful Doppler across the mitral
valve from the apical four chamber views. In this case,
the E/A ratio from early (E) and late (A) flow velocity
and mitral valve deceleration time (MVDT) indicated
diastolic function.
Two-dimensional speckle tracking echocardiography
After being acquired M-mode still images, rats were then
taken the strain and strain rate measurements through
two-dimensional STE images (100 frames per second) ac-
quired from parasternal short-axis view on mid papillary
level in B-mode as previously described [11]. Strain and
strain rate were both quantified in circumferential and ra-
dial axes. In brief, two-dimensional image was frozen at
the end of systole and endocardial border was carefully
and manually traced at LV parasternal short-axis views,
and then epicardium was covered automatically. Tracked
images were divided into six segments including anterior
free wall (AFW), lateral wall (LW), posterior wall (PW),
inferior free wall (IFW), posterior septum (PS) and anter-
ior septum (AS). Then, the peak endocardial systolic radial
and circumferential strain and strain rate of each segment
were analyzed and calculated by Vevo Strain software.
Global strain and strain rate were the average of all six
segments. Finally, diastolic and systolic LV function was
evaluated by the average of three independent cardiac
cycles.
Dobutamine stress test
In 12 weeks, rats were given dobutamine to evaluate the
cardiac function under stress condition using M-mode
echocardiography. Based on Planet’s protocol, cannula-
tion and infusion of 10 g/kg/min of dobutamine from
the tail vein was applied in this test [12]. M-mode still
images of all animals in test were acquired initially and
then time lapse images were captured every two minutes
during the entire infusion period. Finally, images of the
whole process were analyzed and compared.
Isolation of left ventricular cardiac myocytes
Cardiac myocytes from rat left ventricular at 6 weeks
were isolated by retrograde enzymatic perfusion as pre-
viously described with slight modification [13]. In brief,
the rat hearts were quickly excised and fixed on the Lan-
gendorff apparatus. In the initially 7 ~ 8 min, isolated
hearts were perfused with Ca2+-free Joklik medium
working solution (with HEPES added and dissolved in
diluted water followed the instruction, and adjusted to
pH7.2) at 2–3 ml/min to wash out the remnant blood.
The perfusion was then followed the same solution con-
taining 0.5 mg/ml of collagenase and 0.1 % of BSA for
further 35 min. After perfusion the ventricles were sheared,
gently torn up into fragments and the cells were washed in
Joklik’s modified MEM. Subsequently, the suspension was
washed three times and a CaCl2 solution was gradually
added to the final concentration of 1.25 mM by 8 steps
with 5-min interval. Finally, the myocyte suspensions were
stored at room temperature and the following experiments
were performed within 6 h.
Measurement of calcium transient
Isolated cardiac myocytes were loaded onto a calcium
indicator, 1.0 μmol/L Fluo-4/AM at room temperature,
lucifugal. Twenty minutes later, cells were washed twice
and resuspended in physiological buffer containing
132 mM NaCl, 4.8 mM KCl, 1.2 mM MgCl2, 5 mM glu-
cose, 10 mM HEPES and 1.25 mM CaCl2. Then, the sus-
pended cells were placed in a superfusion chamber on
the laser scanning confocal microscope system (LSCM,
Leica, SP5-FCS, Germany). Through a pair of platinum
electrodes positioned in the chamber, myocytes were
initially field-stimulated at 1 Hz at least for 1 min before
measured for minimizing the differences, and then
60 Hz (1 min pulse duration, 5–10 % above threshold)
was applied as the basic stimulating condition. One mi-
nute later, isoproterenol was added with the final con-
centration of 10−9, 10−8, 10−7, 10−6 M stepwise. During
each stimuli, the movement and fluorescent of interest
area was monitored continuously by LSCM. The optical
area was restricted of only a single cell during one experi-
ment duration with a line through the largest diameter
and recorded under the x-t manner. Fluo-4 fluorescent
was measured at 525 nm and its time curve was recorded
automatically.
SDS-polyacrylamide gel electrophoresis (PAGE) and
immunoblotting
Left ventricular myocardium of rats in 6 weeks was
lysed in RIPA buffer containing phosphotase and prote-
ase inhibitors. Protein concentrations were quantified
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using Bio-Rad (Biorad Laboratories, Hercules, CA,
USA). Equal amounts of protein were loaded on 8–
15 % polyacrylamide gels and subjected to SDS-PAGE,
then electrotransferred onto PVDF membranes (Milli-
pore Corporation, Bedford, MA, USA) and immuno-
blotted using: anti-phosphoryl-phosphlamban (Ser16)
(rabbit polyclonal, Millipore, #07052), anti-phosphoryl-
phosphlamban (Thr17) (rabbit polyclonal, Santa Crutz,
sc-17024-R), anti-phospholamban (rabbit polyclonal,
Cell Signaling,#8495); anti-phosphoryl-CaMKII (T287)
and anti-CaMKII (rabbit polyclonal, abcam, ab32678
and ab52476); anti- phosphoryl-AMPKα(Thr172) and
anti-AMPKα (rabbit polyclonal, Cell Signaling, #2513
and #2532); anti-ATP2a/SERCA2 (rabbit mAb, Cell
Signaling, #9580), anti-Sirt1 (mouse monoclonal, Cell
Signaling, #8469) antibodies. All antibodies were used
in 1:1000 dilutions unless indicated otherwise in the text.
Antigen-antibody complexes were detected using anti-
rabbit or anti-mouse antibodies conjugated to horseradish
peroxidase (HRP) and visualized using SuperSignal chemi-
luminescent detection kit (Pierce, Rockford, Ill, USA).
HRP-conjugated anti-GAPDH (Kangcheng, China,KC-
5G5) and α-tubulin (Cell Signaling, #2144) was used to
ensure equal loading of protein samples.
Masson’s TRICHROME STAINING analysis
Left ventricular wall of 6 and 12 weeks rats were fixed
with 10 % formalin and embedded in paraffin. Slices
were serially cut within 5 μm thickness and were all
cross sections. Then the instruction of Masson’s Tri-
chrome stain kit was followed and microscope was used
to get the pictures.
Statistic analysis
All values were presented as the mean ± standard deviation
(SD). Data were subjected to Student’s t test for two-way
unpaired analysis of variance between two groups using
GraphPad Prism 1.1 program. The P values less than 0.05
were considered significant.
Results
Induction of type 2 diabetes in rats through the low-dose
of STZ and high-fat diet
Seven days after injection of STZ, blood samples were col-
lected from tail vein. The successful induction of diabetes
was confirmed by measuring the fasting blood glucose
concentration (FPG) and random blood glucose concen-
tration (RPG) in model rats. According to the diagnosis
standard of type 2 diabetes, rats with RPG level over
11 mM and/or FPG level over 7 mM in two consecutive
measurements were considered as diabetic. On day 7, 16
out of 20 rats started to show signs of diabetes. Therefore,
the induction successful rate was 80 %. By the end of
3 weeks, the average levels of fasting plasma glucose
(FPG) and 2-h plasma glucose (2 h PG) in control group
were 5.4 ± 1.0 mmol/L and 6.9 ± 1.2 mmol/L, respectively,
whereas the same values were increased 2–3 folds in the
model group. OGTT and ELISA test showed that at all
time points, the plasma glucose levels in model rats
were higher than that of the control (P < 0.05) (Fig. 1)
but insulin level in serum did not differ significantly
(P > 0.05), indicating that these animals had acquired
T2DM (Table 1). Then, the diabetic condition was sta-
bly maintained and closely monitored. All DM rats ap-
peared to be otherwise healthy and survived for at least
6 weeks. One T2DM rat died at about 10 weeks after
disease induction, and another one died approximately
13 min after dobutamine infusion in a later test. None
of the rats in control group died during the study
period.
Detection of early diabetic cardiac dysfunction by
echocardiography
To compare different methods for detection of diabetic
cardiac performance, half of the control and model rats
were examined firstly by traditional M-mode and
colour Doppler to evaluate the LV systolic and diastolic
function (Fig. 2). As shown in Table 2, the EF%
and FS% were slightly reduced about 6 and 8 %,
Fig. 1 The time course curve of OGTT of rats in 7 days after the
induction treatment. Data are presented as mean ± SD. Plasma
glucose of model rats was significantly higher than that of the
control at all time points before and after glucose lavage. * P < 0.05;
# P < 0.01
Table 1 Blood glucose level of rats at 3 weeks. Data are
presented as mean ± SD.







Control 16 5.4 ± 1.0 6.9 ± 1.2 3.32 ± 1.01
Model 16 10.1 ± 7.3# 18.8 ± 7.6# 2.83 ± 1.07
#Compared to control group, P<0.01
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respectively, in model group at 6 weeks, and 11 and
14 %, respectively, at 12 weeks. However, the differ-
ences were not statistically significant. The average
thickness of LV anterior wall was nearly identical be-
tween control and model groups at 6 and 12 weeks.
Also, there was no significant difference between the
control and model groups in either end-diastolic and
end-systolic diameters or volumes. Meanwhile, the E/A
ratio did not differ significantly between the two groups.
Furthermore, when the model rats were treated with
dobutamine infusion, the levels of EF% and FS% were
steadily increased in control group but to a much less
extent than that in the model group (Fig. 3). The diastolic
function as measured by LV diameter and volume, was
Table 2 Measurements of left ventricular (LV) function in rats by M-mode echocardiography from the parasternal short axis at the
mid papillary muscle level, and colourful-Doppler across the mitral valve from the apical four chamber views
6 Weeks 12 Weeks P-value
Control Rats Model Rats Control Rats Model Rats P1 P2 P3 P4
(n = 8) (n = 8) (n = 8) (n = 7)
AWD(mm) 1.82 ± 0.20 1.82 ± 0.17 1.74 ± 0.22 1.74 ± 0.25 0.9445 0.4912 0.7806 0.3278
AWS (mm) 2.86 ± 0.39 2.89 ± 0.32 2.59 ± 0.38 2.43 ± 0.19 0.9521 0.1701 0.2972 0.0091
PWD (mm) 2.15 ± 0.22 2.01 ± 0.33 1.87 ± 0.19 1.70 ± 0.23 0.3284 0.1142 0.0230* 0.0652
EDD (mm) 7.44 ± 0.39 7.69 ± 0.99 7.47 ± 0.57 7.58 ± 0.57 0.5227 0.7959 0.6183 0.6498
EF (%) 72.61 ± 6.38 68.19 ± 8.64 66.37 ± 7.06 59.34 ± 5.27 0.2641 0.0629 0.0724 0.0651
FS (%) 43.33 ± 5.46 39.82 ± 7.03 38.22 ± 5.74 32.69 ± 3.65 0.2842 0.0613 0.0748 0.0330*
EDV (ml) 293.78 ± 32.90 321.15 ± 93.93 308.12 ± 51.21 299.13 ± 58.17 0.4496 0.8122 0.5800 0.6012
ESV (ml) 80.28 ± 19.33 106.38 ± 48.40 105.11 ± 31.42 124.43 ± 35.19 0.1784 0.2979 0.0782 0.4485
E/A Ratio 1.54 ± 0.17 1.83 ± 0.51 1.68 ± 0.26 1.56 ± 0.18 0.1477 0.3586 0.2440 0.2109
MVDT(ms) 14.17 ± 5.80 17.45 ± 8.91 16.03 ± 2.56 16.77 ± 2.96 0.3969 0.6258 0.4473 0.8504
Data are presented as mean ± SD. Abbreviations AWD anterior wall in diastole, AWS anterior wall in systole, PWD posterior wall in diastole, EDD end-diastolic diameter, EF
ejection fraction, FS fractional shortening, EDV end-diastolic volume, ESV end-systolic volume, E/A Ratio ratio of the early (E) to late (A) ventricular filling velocities, MVDT
mitral valve deceleration time
P1 and P2, Model group compared to control group; P3 and P4, 12-week compared to 6-week group, *P<0.05
Fig. 2 a-e: typical analysis pictures of radial and circumferential strain and strain rate from the view of parasternal short axis (at the mid papillary
muscle level) of control rats; f-j: typical analysis pictures of radial and circumferential strain and strain rate from the view of parasternal short axis
(at the mid papillary muscle level) of model rats
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relatively stable, whereas systolic function was increased
in the control group. The model rats showed comparable
diastolic function to that of the control group, whereas
they showed a lower capacity for systolic reaction under
stress conditions, which indicated cardiac dysfunction.
In parallel, the remaining control and model rats were
subjected to two-dimensional STE analysis. Strain and
strain rate in both control and model groups at 6 weeks
are shown in Table 3. During the diastolic phase, S and Sr
in radial and circumferential direction were all affected in
the model rats. Control and model rats showed significant
differences (P < 0.05) in global and all segmental strain, as
well as partially in some segmental strain rate During the
systolic phase, differences between the control and model
rats were observed in both radial and circumferential
strains and strain rates, although most of the differences
(except LW and PW strain rates) were not statistically sig-
nificant. These results indicated the presence of diastolic
dysfunction in model rats in the early days of the disease,
which can be detected by the two-dimensional STE.
Impaired Ca2+ handling in diabetic rats and its possible
molecular mechanisms
The Ca2+ handling were examined in diabetic rats. To
this end, cardiomyocytes were isolated from both control
and model rats at 6 weeks and the Ca2+ transient was
measured as described in Materials and Methods. As
shown in Fig. 4, the time to peak (Tpeak) of the Ca
2+
transient was similar between control and model rats,
but the time of 50 % decay from peak (Tdecay1/2) was sig-
nificantly delayed in model rats (P < 0.05). To investigate
the calcium handling capacity of cells under stress, cells
were then treated with different dose of isoproterenol
(ISO). The results showed that at higher ISO dosages,
there were significant differences between cells from con-
trol and model groups (P < 0.05). These results suggested
Fig. 3 M-mode echocardiography measurement of left ventricular of rats during dobutamine infusion (10 g/kg/min) from tail intravenous at
12 weeks. The statistically differences of EF%, FS%, ESD and ESV between the two groups could be detected. * P < 0.05; # P < 0.01; Abbreviations:
EF = ejection fraction; FS = fractional shortening; EDD = end-diastolic diameter; ESD = end-systolic diameter; EDV = end-diastolic volume;
ESV = end-systolic volume
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that Ca2+ handling was impaired in cardiomyocytes of
model rats.
The cellular proteins involved in the regulation of cal-
cium transients and diabetic cardiac dysfunction in these
animals were analyzed by western blotting. In this re-
gard, As shown in Fig. 5, the expression of SERCA did
not differ between control and model rats, whereas the
phosphorylation of PLB at Ser 16 elevated significantly
and somewhat increased at Thr17. On the other hand,
the phosphorylation of CaMKII was decreased more
than 70 % (P < 0.05). The detection of the expression of
adenosine 5’-monophosphate (AMP)-activated protein
kinase (AMPK) and its key regulator Sirt1 showed that
the total protein level of AMPK remained unchanged in
model rats, whereas the phosphorylation of AMPK at
Thr172 and the expression of Sirt1were both reduced by
approximately 50 % (P < 0.05) (Fig. 4).
Discussion
In many aspects, the cardiac dysfunction characteristic
of type 1 and type 2 diabetes in humans can be repro-
duced in rodent models [8]. Most studies to date have
focused on the use of transgenic mice. Consistent with
previous studies [9, 10], our data showed that low-dose
(30 mg/kg) STZ and a high-fat diet could induce T2DM
in rats, and the blood insulin test results (Table 1)
Table 3 Peak regional and global strain and strain rate of rats at 6 weeks measured through STE. Views were detected from the
parasternal short axis at the mid papillary muscle level
Strain Strain Rate
Control Rats Model Rats P Control Rats Model Rats P
(n = 8) (n = 8) (n = 8) (n = 8)
Diastolic Radial AFW −36.04 ± 12.68 −9.05 ± 10.10 <0.001# −11.06 ± 4.14 −7.63 ± 1.99 0.1144
LW −24.86 ± 4.25 −10.16 ± 7.58 <0.001# −9.62 ± 2.87 −5.79 ± 1.37 0.0087#
PW −25.03 ± 11.78 −10.39 ± 9.79 0.0076# −8.37 ± 3.04 −5.58 ± 1.77 0.0299*
IFW −29.12 ± 13.97 −11.21 ± 12.85 0.0126* −8.52 ± 2.03 −6.64 ± 1.78 0.0453*
PS −22.88 ± 12.69 −6.24 ± 4.63 0.0031# 7.07 ± 2.99 −5.78 ± 2.03 0.2376
AS −21.64 ± 13.99 −4.24 ± 4.75 0.0209* −6.89 ± 2.27 −7.07 ± 1.71 0.7496
Average −26.63 ± 9.04 −7.05 ± 5.97 <0.001# −9.13 ± 2.51 −6.62 ± 1.16 0.0304*
Circumferential AFW 26.29 ± 12.24 1.43 ± 0.99 <0.001# 7.64 ± 2.77 4.44 ± 2.45 0.0417*
LW 27.35 ± 13.97 2.95 ± 2.63 <0.001# 7.31 ± 2.73 3.14 ± 2.02 0.0045#
PW 31.07 ± 11.35 0.80 ± 0.34 <0.001# 8.06 ± 1.71 5.36 ± 1.92 0.0094#
IFW 29.44 ± 19.96 0.81 ± 1.04 <0.001# 10.53 ± 6.33 5.74 ± 2.93 0.0789
PS 29.77 ± 19.52 0.90 ± 0.46 0.0010# 8.10 ± 2.44 8.75 ± 6.02 0.7597
AS 21.32 ± 8.25 0.66 ± 0.40 <0.001# 6.25 ± 2.31 5.96 ± 1.80 0.9022
Average 29.57 ± 14.35 1.25 ± 0.69 <0.001# 7.98 ± 2.37 5.65 ± 2.55 0.1008
Systolic Radial AFW 38.72 ± 10.04 23.92 ± 9.61 0.0537 9.79 ± 6.05 4.76 ± 1.79 0.0407*
LW 26.89 ± 14.94 19.44 ± 8.94 0.2461 7.76 ± 3.56 4.04 ± 1.83 0.0229*
PW 25.87 ± 14.55 19.77 ± 10.01 0.3456 7.15 ± 1.54 3.97 ± 1.75 0.0012#
IFW 24.83 ± 10.11 17.33 ± 10.48 0.1671 8.20 ± 3.16 4.30 ± 2.44 0.0158*
PS 16.91 ± 6.25 10.63 ± 8.49 0.1144 6.93 ± 1.84 4.13 ± 2.82 0.0211*
AS 25.73 ± 19.00 19.19 ± 7.47 0.3801 5.71 ± 2.15 4.02 ± 2.33 0.1817
Average 26.13 ± 9.75 18.12 ± 5.56 0.0630 8.67 ± 2.59 4.23 ± 1.94 0.0022#
Circumferential AFW −23.39 ± 8.39 −15.77 ± 9.22 0.1495 −6.74 ± 2.81 −4.86 ± 3.78 0.3395
LW −20.64 ± 6.31 −10.34 ± 12.62 0.0584 −6.54 ± 2.31 −2.37 ± 1.29 0.0010#
PW −21.98 ± 4.79 −19.57 ± 8.18 0.5102 −7.11 ± 1.41 −5.26 ± 1.24 0.0238*
IFW −24.04 ± 7.22 −21.58 ± 10.30 0.3488 −7.42 ± 2.52 −5.45 ± 1.62 0.1154
PS −23.00 ± 3.23 −27.95 ± 10.02 0.2074 −8.25 ± 2.92 −7.68 ± 4.87 0.8873
AS −19.84 ± 7.12 −24.72 ± 8.53 0.1340 −5.61 ± 1.78 −6.60 ± 3.31 0.3478
Average −22.01 ± 3.87 −19.99 ± 7.67 0.5314 −6.95 ± 1.98 −5.65 ± 3.18 0.4198
Data are presented as mean ± SD. Abbreviations: AFW anterior free wall, LW lateral wall, PW posterior wall, IFW inferior free wall, PS post septum, AS anterior septum
*Compared to control group, P<0.05; #Compared to control group, P<0.01
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showed that this low dose of STZ did not significantly
affect the insulin secretion function of islet beta-cells.
Therefore, the ability of this model to mimic T2DM in rats
makes it suitable for research studies. In the present study,
the intraperitoneal injection of STZ was also replaced by
tail vein. This replacement ensured the complete drug ab-
sorption, led to an 80 % success rate of induction of the
disease only after 7 days of the treatment, which was much
more efficient than what was in showed in the previous
report.
In this study, M-mode echocardiography detected
somewhat weak signs of systolic dysfunction in the early
stages of disease (Table 2). Compared rats in 6-weeks,
only the PWD of the control and FS% of the model in
12-weeks decreased, it showed that the effect of pro-
longation of the age or hyperglycaemic status on the car-
diac function were still not obvious. And the differences
between the two groups, for certain parameters, such as
EF% and FS%, the levels in model rats were slightly
lower than those of the controls. The change was not
significant until 12 weeks, and the difference was de-
tected only after dobutamine inducing. No significant
differences in the E/A ratio were detected between the
two groups. By contrast, the LV deformation in model
rats was detected by STE at 6 weeks. These results dem-
onstrated that the sensitivity of STE versus conventional
M-mode measurements. As a simpler and more access-
ible measurement method, M-mode echocardiography
remains the first option for cardiac function evaluation
in the clinic; however, the significance of STE has been
demonstrated and the method has been gradually uti-
lized, especially for data collection on the cardiac func-
tion of patients with preserved ejection fraction [7].
Evidence obtained through the use of this technology in
the clinic has demonstrated the existence of subclinical
cardiac dysfunction in the early stages of T2DM. How-
ever, there are few studies using STE in small animals,
including the present work. Previously, in Li’s report
[11], LV deformation in systole could be detected in db/
db mice at 16 weeks of age. Our data showed that in
T2DM diabetic rats induced by low-dose STZ and a
high-fat diet, although the LV strain in systole at 6 weeks
remained unchanged, the strain rate in some segments
and the global strain rate in the radial direction could
both be detected (Table 3). This indicated the different
characteristics of the disease development in this model
compared with that in db/db mice. Furthermore, our
analysis showed that in this period of the disease, not
only the deformation of the LV could be found in sys-
tole, but also in diastole, and the latter was more severe
than the former. These findings are consistent with
clinical trends, which show that in T2DM patients, the
Fig. 4 The calcium transient images before ISO treatment and values of isolated rat cardiomyocytes at 6 weeks. In control group, 32 cells were
measured from 5 rats, whereas in model group 36 cells were measured from the same number of rats. Cells were electrically paced with 60 Hz
current with or without isoprenaline (ISO) treatment. a: calcium transient image of cardiomyocyte of the control rat; b: calcium transient
image of cardiomyocyte of the model rat. Data are presented as mean ± SD. Abbreviations: Tpeak = Time to peak; Tdecay1/2 = Time of 50 %
decay from peak. Compared the control, the Tdecay1/2 of cardiomyocytes of model rats was significantly increased before and after ISO
treatment. * P < 0.05; # P < 0.01
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cardiac diastolic dysfunction occurs earlier than the
systolic dysfunction.
The contractility-relaxation of cardiomyocytes and the
condition of myocardial connective tissues affect the
motion of the cardiac wall. Generally, connective tissue
deposition is a late event during the development of
DM. In the present study, histological analysis revealed
few, if any, sign of fibrosis in diabetic rats in the early
weeks (Fig. 6). Meanwhile, we found that the Ca2+tran-
sients of left ventricular cardiomyocytes were delayed in
Fig. 5 Western blotting analysis of the expression of key players of calcium transient and AMPK, Sirt1 in LV myocardium of rats. Data are presented as
mean ± SD. GAPDH and α-tubulin were performed to ensure the equal loading of protein samples. Compared the control, the expression of PLN-p-
S16 in model rats’ LV myocardium was increased whereas the Sirt1, AMPK-p and CaMKII-p-Thr287 were all decreased remarkably. * P < 0.05; # P < 0.01
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these animals (Fig. 4); this was significant in theTdecay1/2
and even more evident upon ISO stress. These findings
suggested that in the early stage of our model rats, the
LV deformation may be due to the affected cardiomyo-
cyte relaxation-contractility caused by the intracellular
calcium handling damage. SERCA-2a acts as a key
factor in the uptake of Ca2+into the sarcoplasmic
reticulum (SR) which determines the intracellular calcium
transportation dynamics and thus the cardiomyocyte
relaxation-contractility. Previous studies have reported
that in diabetic animals, the protein or activity level of
SERCA-2a was decreased contributing to the cardiac dys-
function, but these reports was mainly focused on type 1
models and/or type2 diabetic rats at later stages of the dis-
ease [14–17]. In the present study, in T2DM rats at
6 weeks, the expression of SERCA-2a in cardiomyocytes
remained unchanged, and its key modulator, PLB, showed
a higher phosphorylation rate (Fig. 4). This indicated the
possible up-regulation of the activity of the SERCA pump
and an improved calcium transportation capability. Simi-
lar findings has been reported by Miklo et al [18], showing
that in 6-week metabolic syndrome rats, LV cardiomyo-
cytes were declined in Ca2+ sequestration capacity, while
SERCA activity remained intact. These facts imply that in
the early stage of the fat-overloaded and hyperglycemic
status, the uptake of Ca2+ to the SR may be delayed, which
affects the normal processes of cardiomyocyte relaxation-
contractility; whereas SERCA, and its primary regulator
PLN, may remain normal or even stronger to compensate
for this abnormality. On the other hand, an interestingly
thing is that in the present study, additional experiments
found that in these T2DM rats, CaMKIIphosphorylation
was attenuated remarkably in the LV myocardium. CaM-
KII is an important molecule that plays a role in calcium
homeostasis. It can modulate PLN and RyR function
through phosphorylation, and studies found that this
protein also has an autophosphorylating function at
Thr287 to confer Ca2+/CaM-independent activity. When
the autophosphorylated isoform is activated, it can sustain
CaMKII activity even in the absence of elevated Ca2+
/CaM, thus extending the CaM-dependent regulation
[19]. However, whether CaMKIIabnormality affects car-
diac function in T2DM remains unclear. Our findings
indicate that in the early stages of T2DM, the activity
of CaMKIIis decreased, which could be attributed to al-
terations in calcium homeostasis in the heart caused by
its down-regulation and the consequent inhibition of
downstream targets such as PLN. Due to the limitations
of our experiments, at present we were unable to pro-
vide more evidence supporting our thoughts, but in
previous report [20], study found that the depression of
Thr287-autophosphorylation could lead to calcium transi-
ent delay and cardiomyocyte diastolic function, contribut-
ing to the increased arrhythmia, hence this fact might be a
circumstantial evidence to support this hypothesis.
In T2DM, the myocardium energetic metabolism was
remodelled, which could affect the capability of calcium
homeostasis of cardiomyocytes [21, 22]. AMPK is a
major regulator of cardiac metabolism, including lipid
oxidation and glucose uptake [23], and the suppression
Fig. 6 Masson’s Trichrome Staining analysis. The normal cardiomyocytes were stained red, and fibrotic areas were stained green as usual. The
results showed that till 12 weeks there was no significant fibrosis could be observed in model rats myocardium. Pictures were taken with
5 × objective lens
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of AMPK signalling pathway is found in the process of
diabetic cardiomyopathy. In addition, AMPK can activate
cardiac troponin I (cTnI), which has a direct positive effect
on myocardial contractility at the myofilament level [24].
In this study, we found that the expression level of AMPK
was not affected, but its phosphorylation status was re-
markably diminished during the onset of T2DM in rat,
similar to the expression of its positive regulator Sirt1
(Fig. 4). These findings suggested that metabolic remodel-
ling was involved in the initial stage of the process of
T2DM in rats. Reports have shown an inverse relationship
between the cardiac diastolic strain rate and the myocar-
dial triglyceride content through strain-encoded magnetic
resonance analysis of T2DM patients, although the pa-
tients’ systolic function was preserved [25, 26]. This clin-
ical information taken together with our results indicates
that there is a relationship between energy remodeling
and myocardial deformation, and the cardiomyocyte intra-
cellular SIRT1/AMPK signaling pathway may play a role
in this association.
Conclusions
In conclusion, in the present study, a rat model of T2DM
was established by low dose STZ and a high-fat diet. Using
these model rats, LV deformation occurred at the early
stages of the disease and was associated with calcium tran-
sient delay. The downregulation of the activity of the
CaMKII and SIRT1/AMPK signaling pathways could be
attributed to cardiomyocyte intracellular calcium handling
impairment and myocardial deformation. These results
suggest a role for metabolic remodeling in the onset of
DCM in rats, and the current animal model of T2DM
provides a useful tool for further investigation of the eti-
ology of this disease.
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